Individual variation in sleep quality and duration is related to cerebral Mu opioid receptor binding potential during tonic laboratory pain in healthy subjects

Pain Medicine (United States)

Volumn 14, Issue 12, 2013, Pages 1882-1892

  Campbell, Claudia M ^a   Bounds, Sara C ^a   Kuwabara, Hiroto ^a   Edwards, Robert R ^b   Campbell, James N ^a   Haythornthwaite, Jennifer A ^a   Smith, Michael T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Binding Potential; Capsaicin; Imaging; Pain; PET; Sleep

Indexed keywords

CARFENTANIL; MU OPIATE RECEPTOR;

ANTERIOR CINGULATE; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; INSULA; MALE; NEUROIMAGING; NOCICEPTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PITTSBURGH SLEEP QUALITY INDEX; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; RECEPTOR BINDING; SLEEP QUALITY; SLEEP TIME; TEMPORAL LOBE; THALAMUS;

BINDING POTENTIAL; CAPSAICIN; IMAGING; PAIN; PET; SLEEP; [11C]CARFENTANIL;

ADULT; BRAIN; FEMALE; HEALTHY VOLUNTEERS; HUMANS; MALE; PAIN; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, OPIOID, MU; SLEEP;

EID: 84890229567     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12231     Document Type: Article

References (60)

1. Foo H, Mason P. Brainstem modulation of pain during sleep and waking. Sleep Med Rev 2003;7(2):145-154.
2. Watson CJ, Lydic R, Baghdoyan HA. Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine. Neuroscience 2007;144(1):375-386.
3. Wittig RM, Zorick FJ, Blumer D, Heilbronn M, Roth T. Disturbed sleep in patients complaining of chronic pain. J Nerv Ment Dis 1982;170(7):429-431.
4. Campbell CM, Bounds SC, Simango MB, etal. Self-reported sleep duration associated with distraction analgesia, hyperemia, and secondary hyperalgesia in the heat-capsaicin nociceptive model. Eur J Pain 2011;15(6):561-567.
5. Gupta A, Silman AJ, Ray D, etal. The role of psychosocial factors in predicting the onset of chronic widespread pain: Results from a prospective population-based study. Rheumatology (Oxford) 2007;46(4):666-671.
6. Kaila-Kangas L, Kivimaki M, Harma M, etal. Sleep disturbances as predictors of hospitalization for back disorders-a 28-year follow-up of industrial employees. Spine 2006;31(1):51-56.
7. Mikkelsson M, Sourander A, Salminen JJ, Kautiainen H, Piha J. Widespread pain and neck pain in schoolchildren. A prospective one-year follow-up study. Acta Paediatr 1999;88(10):1119-1124.
8. Siivola SM, Levoska S, Latvala K, etal. Predictive factors for neck and shoulder pain: A longitudinal study in young adults. Spine 2004;29(15):1662-1669.
9. Castillo RC, MacKenzie EJ, Wegener ST, Bosse MJ. Prevalence of chronic pain seven years following limb threatening lower extremity trauma. Pain 2006;124(3):321-329.
10. Smith MT, Klick B, Kozachik S, etal. Sleep onset insomnia symptoms during hospitalization for major burn injury predict chronic pain. Pain 2008;138(3):497-506.
11. Edwards RR, Almeida DM, Klick B, Haythornthwaite JA, Smith MT. Duration of sleep contributes to next-day pain report in the general population. Pain 2008;137(1):202-207.
12. Smith MT, Edwards RR, McCann UD, Haythornthwaite JA. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 2007;30(4):494-505.
13. Fadda P, Martellotta MC, De Montis MG, Gessa GL, Fratta W. Dopamine D1 and opioid receptor binding changes in the limbic system of sleep deprived rats. Neurochem Int 1992;20(suppl):153S-156S.
14. Przewlocka B, Mogilnicka E, Lason W, van Luijtelaar EL, Coenen AM. Deprivation of REM sleep in the rat and the opioid peptides beta-endorphin and dynorphin. Neurosci Lett 1986;70(1):138-142.
15. Fadda P, Tortorella A, Fratta W. Sleep deprivation decreases mu and delta opioid receptor binding in the rat limbic system. Neurosci Lett 1991;129(2):315-317.
16. Ukponmwan OE, Rupreht J, Dzoljic MR. REM sleep deprivation decreases the antinociceptive property of enkephalinase-inhibition, morphine and cold-water-swim. Gen Pharmacol 1984;15:255-258.
17. Nascimento DC, Andersen ML, Hipolide DC, Nobrega JN, Tufik S. Pain hypersensitivity induced by paradoxical sleep deprivation is not due to altered binding to brain mu-opioid receptors. Behav Brain Res 2007;178(2):216-220.
18. Frecska E, Perenyi A, Arato M. Blunted prolactin response to fentanyl in depression. Normalizing effect of partial sleep deprivation. Psychiatry Res 2003;118(2):155-164.
19. Zgierska A, Brown RT, Zuelsdorff M, etal. Sleep and daytime sleepiness problems among patients with chronic noncancerous pain receiving long-term opioid therapy: A cross-sectional study. J Opioid Manag 2007;3(6):317-327.
20. Raymond I, Nielsen TA, Lavigne G, Manzini C, Choiniere M. Quality of sleep and its daily relationship to pain intensity in hospitalized adult burn patients. Pain 2001;92(3):381-388.
21. Raymond I, Ancoli-Israel S, Choiniere M. Sleep disturbances, pain and analgesia in adults hospitalized for burn injuries. Sleep Med 2004;5(6):551-559.
22. Steinmiller CL, Roehrs TA, Harris E, etal. Differential effect of codeine on thermal nociceptive sensitivity in sleepy versus nonsleepy healthy subjects. Exp Clin Psychopharmacol 2010;18(3):277-283.
23. Villanueva L, Le Bars D. The activation of bulbo-spinal controls by peripheral nociceptive inputs: Diffuse noxious inhibitory controls. [Review] [96 refs]. Biol Res 1995;28(1):113-125.
24. Edwards RR, Grace E, Peterson S, etal. Sleep continuity and architecture: Associations with pain-inhibitory processes in patients with temporomandibular joint disorder. Eur J Pain 2009; 13(10):1043-1047.
25. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005;9(4):463-484.
26. Campbell CM, Quartana PJ, Buenaver LF, Haythornthwaite JA, Edwards RR. Changes in situation-specific pain catastrophizing precede changes in pain report during capsaicin pain: A cross-lagged panel analysis among healthy, pain-free participants. J Pain 2010;11(9):876-884.
27. Anderson WS, Sheth RN, Bencherif B, Frost JJ, Campbell JN. Naloxone increases pain induced by topical capsaicin in healthy human volunteers. Pain 2002;99(1-2):207-216.
28. Bencherif B, Fuchs PN, Sheth R, etal. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET). Pain 2002;99(3):589-598.
29. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28(2):193-213.
30. Wager TD, Scott DJ, Zubieta JK. Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A 2007;104(26):11056-11061.
31. Rahmim A, Cheng JC, Blinder S, Camborde ML, Sossi V. Statistical dynamic image reconstruction in state-of-the-art high-resolution PET. Phys Med Biol 2005;50(20):4887-4912.
32. Hammers A, Allom R, Koepp MJ, etal. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp 2003;19(4):224-247.
33. Mazziotta JC, Toga AW, Evans A, Fox P, Lancaster J. A probabilistic atlas of the human brain: Theory and rationale for its development. The International Consortium for Brain Mapping (ICBM). Neuroimage 1995;2(2):89-101.
34. Ashburner J, Friston KJ. High-dimensional image warping. In: Frackowiak RSJ, Friston C, Frith C, etal., eds. Human Brain Function, 2nd edition. San Diego, CA: Academic Press; 2003:673-694.
35. Ashburner J, Friston KJ. Rigid body registration. In: Frackowiak RSJ, Friston C, Frith C, etal., eds. Human Brain Function, 2nd edition. San Diego, CA: Academic Press; 2003:635-654.
36. Logan J, Fowler JS, Volkow ND, etal. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996;16(5):834-840.
37. Endres CJ, Bencherif B, Hilton J, Madar I, Frost JJ. Quantification of brain mu-opioid receptors with [11C]carfentanil: Reference-tissue methods. Nucl Med Biol 2003;30(2):177-186.
38. Nofzinger EA. Functional neuroimaging of sleep disorders. Curr Pharm Des 2008;14(32):3417-3429.
39. Tracey I. Neuroimaging of pain mechanisms. Curr Opin Support Palliat Care 2007;1(2):109-116.
40. Harris RE, Clauw DJ, Scott DJ, etal. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 2007;27(37):10000-10006.
41. Jones AK, Cunningham VJ, Ha-Kawa S, etal. Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis. Br J Rheumatol 1994;33(10):909-916.
42. Maarrawi J, Peyron R, Mertens P, etal. Differential brain opioid receptor availability in central and peripheral neuropathic pain. Pain 2007;127(1-2):183-194.
43. Baciu MV, Bonaz BL, Papillon E, etal. Central processing of rectal pain: A functional MR imaging study. AJNR Am J Neuroradiol 1999;20(10):1920-1924.
44. Silverman DH, Munakata JA, Ennes H, etal. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 1997;112(1):64-72.
45. Kern M, Hofmann C, Hyde J, Shaker R. Characterization of the cerebral cortical representation of heartburn in GERD patients. Am J Physiol Gastrointest Liver Physiol 2004;286(1):G174-181.
46. Kern MK, Birn RM, Jaradeh S, etal. Identification and characterization of cerebral cortical response to esophageal mucosal acid exposure and distention. Gastroenterology 1998;115(6):1353-1362.
47. Mongini F, Castellano G, Deregibus A, Rota E, Bosco A. Cortical involvement during the description of head pain. J Headache Pain 2006;7(5):351-354.
48. Rosen SD, Paulesu E, Nihoyannopoulos P, etal. Silent ischemia as a central problem: Regional brain activation compared in silent and painful myocardial ischemia. Ann Intern Med 1996;124(11):939-949.
49. Altena E, Van Der Werf YD, Sanz-Arigita EJ, etal. Prefrontal hypoactivation and recovery in insomnia. Sleep 2008;31(9):1271-1276.
50. Dang-Vu TT, Desseilles M, Petit D, etal. Neuroimaging in sleep medicine. Sleep Med 2007;8(4):349-372.
51. Harper RM, Macey PM, Henderson LA, etal. fMRI responses to cold pressor challenges in control and obstructive sleep apnea subjects. J Appl Physiol 2003;94(4):1583-1595.
52. Fillingim RB, Lautenbacher S. The importance of quantitative sensory testing in the clinical setting. In: Lautenbacher S, Fillingim RB, eds. Pathophysiology of Pain Perception. New York: Kluwer Academic Plenum Publishers; 2004.
53. Morris VH, Cruwys SC, Kidd BL. Characterisation of capsaicin-induced mechanical hyperalgesia as a marker for altered nociceptive processing in patients with rheumatoid arthritis. Pain 1997;71(2):179-186.
54. Morris V, Cruwys S, Kidd B. Increased capsaicin-induced secondary hyperalgesia as a marker of abnormal sensory activity in patients with fibromyalgia. Neurosci Lett 1998;250(3):205-207.
55. Lockley SW, Skene DJ, Arendt J. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J Sleep Res 1999;8(3):175-183.
56. Usui A, Ishizuka Y, Obinata I, etal. Validity of sleep log compared with actigraphic sleep-wake state II. Psychiatry Clin Neurosci 1999;53(2):183-184.
57. Van Den Berg JF, Van Rooij FJ, Vos H, etal. Disagreement between subjective and actigraphic measures of sleep duration in a population-based study of elderly persons. J Sleep Res 2008;17(3):295-302.
58. Buysse DJ, Hall ML, Strollo PJ, etal. Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical/polysomnographic measures in a community sample. J Clin Sleep Med 2008;4(6):563-571.
59. Feige B, Al-Shajlawi A, Nissen C, etal. Does REM sleep contribute to subjective wake time in primary insomnia? A comparison of polysomnographic and subjective sleep in 100 patients. J Sleep Res 2008;17(2):180-190.
60. Vanable PA, Aikens JE, Tadimeti L, Caruana-Montaldo B, Mendelson WB. Sleep latency and duration estimates among sleep disorder patients: Variability as a function of sleep disorder diagnosis, sleep history, and psychological characteristics. Sleep 2000;23(1):71-79.